Search Within

Thoracic Oncology

  1. "Adam Schoenfeld"
Formats
  1. Meeting Abstract (63)
  2. Journal Article (56)
  3. Review (4)
  4. Correspondence (3)
  5. Editorial (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (131)
  2. Hematologic Malignancies, Division of (131)
  3. Solid Tumor Oncology Division (131)
  4. Weinberg Fellows (131)
  5. Department of Pathology and Laboratory Medicine (54)
  6. GSK Faculty (52)

More Groups

People
  1. Adam Schoenfeld (131)
  2. Gregory Riely (38)
  3. Marc Ladanyi (36)
  4. Charles Rudin (27)
  5. Arielle Elkrief (26)
  6. Hira Rizvi (26)

More People

Years
  1. 2025 (12)
  2. 2024 (32)
  3. 2023 (24)
  4. 2022 (17)
  5. 2021 (18)
  6. 2020 (17)

More Years

Publications
  1. Journal of Thoracic Oncology (32)
  2. Journal of Clinical Oncology (25)
  3. Clinical Cancer Research (12)
  4. Annals of Oncology (9)
  5. Journal for ImmunoTherapy of Cancer (9)
  6. Cancer Research (5)

More Publications

Publishers
  1. Elsevier Inc. (39)
  2. American Society of Clinical Oncology (27)
  3. American Association for Cancer Research (21)
  4. Oxford University Press (10)
  5. Biomed Central Ltd (9)
  6. Nature Publishing Group (7)

More Publishers

Results (131)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of first-line (1L) nivolumab (N) plus ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)
    Meeting Abstract

    Borghaei, H.; Balli, D.; Paz-Ares, L.; Reck, M.; Ramalingam, S. S.; Brahmer, J. R.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Gainor, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC
    Journal Article

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Letter to the editor: Reply to Zhao, Wu, and Ma
    Correspondence

    Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)
    Meeting Abstract

    Borghaei, H.; Balli, D.; Paz-Ares, L.; Reck, M.; Ramalingam, S. S.; Brahmer, J. R.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Gainor, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Non-viral precision T cell receptor replacement for personalized cell therapy
    Journal Article

    Foy, S. P.; Jacoby, K.; Bota, D. A.; Hunter, T.; Pan, Z.; Stawiski, E.; Ma, Y.; Lu, W.; Peng, S.; Wang, C. L.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Journal Article

    Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Five-year survival outcomes with nivolumab plus ipilimumab versus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer in CheckMate 227
    Journal Article

    Brahmer, J. R.; Lee, J. S.; Ciuleanu, T. E.; Bernabe Caro, R.; Nishio, M.; Urban, L.; Audigier-Valette, C.; Lupinacci, L.; Sangha, R.; Pluzanski, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Analysis of tumor mutational burden, progression-free survival, and local-regional control in patents with locally advanced non-small cell lung cancer treated with chemoradiation and durvalumab
    Journal Article

    Lebow, E. S.; Shepherd, A.; Eichholz, J. E.; Offin, M.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; Schoenfeld, A. J.; Jones, D. R.; Rimner, A.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • A phase I study of personalized adoptive TCR T cell therapy in patients with solid tumors: Safety, efficacy, and T cell trafficking to tumors of non-virally gene edited T cells
    Meeting Abstract

    Foy, S.; Jacoby, K.; Bota, D.; Hunter, T.; Schoenfeld, A.; Pan, Z.; Stawiski, E.; Ma, Y.; Lu, W.; Peng, S. M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save